PV
Palvella Therapeutics, Inc. (PVLA)
NASDAQ·Healthcare·Biotechnology
$108.81
+1.89%
Mkt Cap $1.29B
Analyst Ratings
Buy
17
Hold
0
Sell
0
Price Target (31 analysts)
$203.92
Range $143.00 – $255.00
Implied Upside
+87.4%
Consensus $203.92 vs current $108.81